[23] analysed a larger IPMN follow‐up cohort of n = 112 patients regarding cfDNA quantification and mutant allele frequency (MAF)—concluding that the MAF of KRAS in IPMN patients was significantly increased compared with healthy controls. The gene discussed is KRAS; the disease is pancreatic intraductal papillary-mucinous neoplasm.